Skip to content

Long-term Symptomatic Follow-up of Patients with Long COVID Syndrome

ESTUDIO DE APLICACIÓN DE ESCALAS PARA VALORACIÓN SINTOMÁTICA DEL SÍNDROME DE COVID PERSISTENTE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06879535
Enrollment
80
Registered
2025-03-17
Start date
2022-03-28
Completion date
2025-03-28
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long COVID

Keywords

Long COVID, Long-term follow-up, Symptoms, Scales

Brief summary

The goal of this observational study is to learn about the long-term evolution of long COVID. The main question it aims to answer is: Does the main symptoms of the patients diagnosed with long COVID aproximate to those of patients who have had COVID acute infection without devoloping long COVID? Participants will answer mailed survey questions about their main symptons.

Detailed description

Scales, indexes and questionnaires were mailed to 40 patients with long COVID to evaluate their main symptoms. Fatigue, emotional disorders, sleep disorders, cognitive impairments, dyspnea, physical activity, quality of life and pain were analyzed. The patients were reassessed after three years. The same scales, indexes and questionnaires were also sent to a control group of 40 volunteers of the same age and sex as the cases.

Interventions

None listed

Sponsors

Hospital del Rio Hortega
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* patients older than 18 years old and younger than 75 years old * patients who accepted to participate in the study * patients who have had COVID acute infection * patients who have long COVID (cases)

Exclusion criteria

* patients who refused to participate in the study at any time of the study * patients whose diagnosis of long COVID was revoked during the study (cases)

Design outcomes

Primary

MeasureTime frameDescription
FatigueFrom enrollment to three years laterMFIS scale
Emotional disordersFrom enrollment to three years laterHADS scale
Sleep disordersFrom enrollment to three years laterPSQI
Cognitive impairmentsFrom enrollment to three years laterMFE-30
DyspneaFrom enrollment to three years latermMRC
Physical activityFrom enrollment to three years laterGPAQ
Quality of life (healthcare)From enrollment to three years laterSF-36
Pain (healthcare)From enrollment to three years laterEGDC

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026